Trials / Completed
CompletedNCT00548171
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058
Evaluation of GSK Biologicals' dTpa Booster Vaccine in Adults, Given 10 Years After Previous dTpa Boosting.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 203 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 28 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the efficacy and safety of repeating dTpa booster in adults 10 years after previous booster vaccination with dTpa in a previous clinical study (NCT01267058). Only subjects who received the booster vaccination in a previous clinical study are eligible for participation in this study. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007. No new recruitment will be performed in this booster phase (see inclusion criteria).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Boostrix™ | Intramuscular injection, 1 dose |
Timeline
- Start date
- 2007-11-05
- Primary completion
- 2008-04-30
- Completion
- 2008-04-30
- First posted
- 2007-10-23
- Last updated
- 2020-01-13
- Results posted
- 2019-01-15
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00548171. Inclusion in this directory is not an endorsement.